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ABSTRACT: To improve physical characteristics of plastics such
as flexibility and durability, producers enrich materials with
phthalates such as di-2-(ethylhexyl) phthalate (DEHP). DEHP is
a high production volume chemical associated with metabolic and
immune disruption in animals and humans. To reveal mechanisms
implicated in phthalate-related disruption in the gastrointestinal
system, male and female zebrafish were fed DEHP (3 ppm) daily
for two months. At the transcriptome level, DEHP significantly
upregulated gene networks in the intestine associated with helper T
cells’ (Th1, Th2, and Th17) specific pathways. The activation of
gene networks associated with adaptive immunity was linked to the
suppression of networks for tight junction, gap junctional
intercellular communication, and transmembrane transporters, all
of which are precursors for impaired gut integrity and performance. On a class level, DEHP exposure increased Bacteroidia and
Gammaproteobacteria and decreased Verrucomicrobiae in both the male and female gastrointestinal system. Further, in males there
was a relative increase in Fusobacteriia and Betaproteobacteria and a relative decrease in Saccharibacteria. Predictive algorithms
revealed that the functional shift in the microbiome community, and the metabolites they produce, act to modulate intestinal
adaptive immunity. This finding suggests that the gut microbiota may contribute to the adverse effects of DEHP on the host by
altering metabolites sensed by both intestinal and immune Th cells. Our results suggest that the microbiome−gut−immune axis can
be modified by DEHP and emphasize the value of multiomics approaches to study microbiome−host interactions following chemical
perturbations.
1. INTRODUCTION
Phthalates are widely used as softeners in plastic materials (e.g.,
polyvinyl chloride; PVC), food packaging, cosmetics, children’s
toys, medical products (blood bags, tubing) and other
industrial products. One of the most widely produced
phthalates is di-2-ethylhexyl phthalate (DEHP), which
accounted for approximately 40% of world consumption of
plasticizers in 2014.1 Similar to other phthalates, DEHP is not
covalently bound to the plastic polymer. This enables leaching,
resulting in DEHP becoming pseudopersistent in the environ-
ment and within the body. Significant leaching and
volatilization of phthalates from parental material leads to
ubiquitous exposures in human populations2 and environ-
ments.3 In fact, metabolite biomarkers of eight major
phthalates have been detected in urine in 89% to 98% of the
United States (US) population.4 While there are many routes
of exposure (occupational, direct contact with plastics), diet
remains one of the dominant pathways for contact with
phthalates such as DEHP.5 A recent review showed that
humans are chronically exposed to phthalates, as the majority
of foods (from vegetables to meat) contain phthalates,
dominated by DEHP in the parts per million concentration
range.6,7 Moreover, phthalates are intentionally used as film
coating agents in orally ingested tablets and in numerous types
of modified release drug delivery systems, such as enteric-
coated and delayed-release tablets and enteric-coated capsu-
les.8 Thus, DEHP comes into direct contact with the
gastrointestinal system of the host and its microbiome.
Nevertheless, the effects of DEHP specifically on the complex
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microbiome−gut axis and health outcomes are unknown and
warrant further investigation.
Epidemiological evidence suggests that over a dozen
phthalates present in the environment (food, water, air), and
those derived from household products, exacerbate human
disease with exposure. Phthalates are associated with a higher
incidence of specific cancers (breast and skin cancer), obesity-
related pathology (insulin resistance and type II diabetes), and
neurological conditions (attention-deficit hyperactivity disor-
der) among other diseases.9 DEHP in particular is linked to
metabolic disruption and obesity in children10,11 and
adults,12,13 and more studies associate phthalates with the
impact on adaptive immune system14 and connected adverse
health outcomes, e.g., asthma and allergies.15,16 The effect of
DEHP on adaptive immunity, specifically Th cells, is
corroborated by findings in in vitro and in vivo models that
show that DEHP promotes Th1 and Th17 differentiation and
immune responses characterized by nonphysiological synthesis
of a spectrum of Th cytokines (e.g., Il-4, Il-21, Il-13).14,17,18
Studies focused on understanding the effects of xenobiotics on
the host immune system reveal the importance of the host
microbiome−intestinal immune axis; in addition to a direct
effect, changes in microbial core functions may be responsible
for inflammatory and metabolic disorders.19 Accumulating
evidence indicates that the effect of xenobiotics on gut
microbiome composition and diversity plays a role in
mediating chemical toxicity and may exacerbate human
diseases.20 A recent study using a rodent model showed the
effect of low-dose exposure to diethyl phthalate (DEP) on
composition of gut microbiome, specifically on phyla
Firmicutes and Bacteroidetes;21 however there is a lack of
holistic investigations into the impact of phthalates on a
complex microbiome−gut−immune axis.
Moreover, data are sparse on how environmental chemicals,
such as phthalates, affect the microbiome−gut axis, and there
are fundamental gaps in our understanding of the precise
mechanisms by which chemical-induced microbial shifts affect
the immune system, especially for low, subchronic chemical
exposures. The objective of this study was to determine the
mechanisms by which phthalates impact the gastrointestinal
system and potentially host immunity, with emphasis on the
interaction with the host microbiome. Zebrafish, a widely used
toxicological and human health model, were fed an environ-
mentally relevant concentration of DEHP (3 ppm) in feed for
2 months. The concentration of DEHP used in this study is
within the range of concentrations of DEHP found in food,
specifically with higher levels of fat (tens of mg/kg (ppm))6
and in waste waters.22 To determine the impact of DEHP on
microbiome−gut−immune networks, we analyzed the host
gastrointestinal transcriptome and established a workflow to
analyze the effect on host microbiome community. Last, using
computational approaches, we predict functional changes in
bioactive microbial metabolites related to DEHP exposure. We
hypothesized that a subchronic 2 month exposure to DEHP
would alter the expression of gene networks related to
metabolism and the adaptive immune systems. These data
generate novel insight into plasticizer exposure from both an
environmental as well as a human health perspective.
2. METHODOLOGY
Experimental Design. All experiments were conducted
under the supervision and approval of the University of Florida
Institutional Animal Care and Use Committee (IACUC
no.201708217). Zebrafish (Danio rerio) at ∼8 months of age
were divided into 20 tanks (10 replicate tanks/treatment).
Each tank contained three males and three females. Tanks
were randomly assigned one of two treatments: control
(normal food) or DEHP (3 mg/kg DEHP in food). Methods
for preparation of the diet were previously reported in Buerger
et al.23 Briefly, food was prepared by mixing DEHP (CAS 117-
81-7, Sigma-Aldrich, cat. no. 36735) with 100% menhaden oil,
followed by slow addition to Adult Zebrafish Diet (Zeigler,
Gardner, PA) in a food mixer. Control food was mixed with
menhaden oil alone. Animals were fed 10 mg of their
respective food per day for 8 weeks. The experiment was
performed under stable conditions with water temperatures of
26 ± 1 °C and a 14/10 h light/dark cycle. Fish length and
weight were measured biweekly to assess weight gain and
calculate body mass index (BMI). After the exposure, the fish
were anesthetized and then euthanized with an overdose (250
mg/L) of buffered MS222 (ethyl 3-aminobenzoate methane-
sulfonate) and immediately dissected. Gastrointestinal tissue
(GI) and liver samples were placed on Davidson’s fixative for
histopathological evaluation. Tissue samples (GI, liver, and
fecal content) were also flash frozen in liquid nitrogen and
stored at −80 °C.
The Analysis of DEHP Content in the Feed.
Concentrations of DEHP in the food were measured following
methods previously reported in Buerger et al.23 Briefly, three
subsamples of the bulk food were extracted in 100% Optima
grade acetonitrile (Fisher Scientific, Hampton, NH, USA cat.
no.: A996-1). A subsample of the extract was then analyzed
using an Agilent 7890B gas chromatograph coupled with a
7000C triple quadrupole mass spectrometer. Results from the
three food subsamples were averaged and the standard
deviation calculated.
Transcriptomic Analysis of the Gastrointestinal
Tissue. The gastrointestinal RNA was extracted using a
hand-held homogenizer (Ika T10, Germany) and was
processed using TRIzol Reagent (Thermo Fisher Scientific,
USA), as per the manufacturer’s procedure (N = 10 individuals
per treatment, each collected from separate replicate tanks
within the study). Nucleic acid pellets were reconstituted in
Milli-Q water. Extracted RNA was cleaned and DNase-treated
using Qiagen RNeasy Mini Kit (Qiagen) as per the
manufacturer’s protocol. Samples were assessed for quantity
and quality using a ThermoFisher Qubit 3.0 (RNA high
sensitivity assay kit, Q32852) and the Agilent 2100 Bioanalyzer
(Agilent, USA). Those samples with the highest quality were
used for microarray analysis. The mean RNA Integrity Number
(RIN) for samples was 7.9 (min−max 7.2−9.1). Microarray
processing was performed according to the manufacturer’s
protocols (Agilent LowInput QuickAmp Labeling Kit (#5190−
2331) and laboratory protocols (N = 6−8 per group)).24 The
Agilent Zebrafish platform (4x44K, V3) was used to analyze
the GI transcriptome, and 17 h hybridization was performed
(Agilent hybridization kit (#5188−5242)) according to the
manufacturer’s protocol. Microarray slides were scanned using
an Agilent DNA Microarray Scanner with Surescan high-
resolution technologies and raw data extracted by Agilent
Feature Extraction Software. Raw transcriptomic data are
publicly available at NCBI Gene Expression Omnibus
(accession no. GSE136285). JMP Genomics (v8) were used
to process the raw data, normalize the intensities (1.8 value as
limit of detection of intensity), and perform differentially
expressed genes analysis (DEGs). Differentially expressed
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genes were those with a false discovery rate (FDR) < 0.05. A
total number of 26,482 genes (out of 43813) were successfully
mapped to human homologues using the Name + Alias
function in Pathway Studio (v10). For Gene Set Enrichment
Analysis (GSEA), genes were permutated 1000 times using the
Kolmogorov−Smirnov classic approach as an enrichment
algorithm. To broaden the analysis, all pathways were
expanded to include cell processes and functional classes in
target gene seeds. The enrichment p-value cutoff was set at p <
0.05. Sub-network enrichment analysis (SNEA) was also
performed to determine the specific gene subnetworks affected
by DEHP. The enrichment p-value for gene seeds was set at p
< 0.05.
Selected differentially expressed genes with FDR < 0.05 were
confirmed by quantitative PCR (qPCR; Figure S1). The
samples used for qPCR were identical to those used for
microarrays. To perform qPCR, 1 μg of column purified RNA
(N = 6−8 individuals from different tanks per group) was
converted to cDNA using iScript (BioRad, USA) and the T100
Thermal Cycler (BioRad, USA). We followed the best practice
according to Buerger at al.23 that includes all standard controls
(No Reverse Transcriptase (NRT) and No Treatment
Controls (NTC)).
Real-time PCR (qPCR) was performed using the CFX
Connect Real-Time PCR Detection System (BioRad, USA)
with SsoFast EvaGreen Supermix (BioRad, Hercules, CA,
USA). Primer sets for target genes were collected from the
literature or designed with Primer 3, and the cycling
parameters were initiated at 95 °C (30 s) followed by 39
cycles of 95 °C (5 s) and 55 °C (7 s). The dissociation melt
curve was generated, starting at 65.0 and ending at 95.0 °C,
with increments of 0.5 °C every 5 s. Each primer set was tested
for linearity and efficiency generated by a dilution series from a
cDNA pool of zebrafish GI tissue. Two reference genes (rib12
and b2m) were assessed for normalization using CFX Manager
software and used for normalization (M stability value of 0.91,
CV = 0.34) after being deemed appropriate. Normalized gene
expression was extracted using CFX Manager with the relative
ΔΔCq method (baseline subtracted). The results were
statistically evaluated using Kruskal−Wallis nonparametric
ANOVA test performed using GraphPad Prism 5.0.
Fecal Sample Preparation and 16S Sequencing. Fecal
samples (N = 10−13 individuals were measured, with at least
one fish collected from each tank replicate) were extracted
using the Zymo Quick-DNA Fecal/Soil Microbe Miniprep Kit
(D6010) using beads for sample homogenization. Extracted
DNA was quantified using the Qubit ThermoFisher and the
dsDNA HS Assay Kit (Q32851/Q32854). Following this,
samples were adjusted to 5 ng/μL. The AccuPrime PCR
protocol was used to amplify the 16S (V3 and V4) region using
AccuPrime Taq DNA Polymerase (ThermoFisher Scientific
Cat. No: 12346−086) according to the manufacturer’s
instruction. The amplicon size was verified by agarose gel
electrophoresis for the correct amplicon size (∼500−600 base
pairs). The PCR amplicon was purified by magnetic beads
AMPure XP Beads (A63880). We indexed the samples by
Nextera XT DNA Library Preparation Kit (FC-131-2004) with
AccuPrime Taq DNA Polymerase, High Fidelity (12346-086)
and Nextera XT Index primers (S513−S522, N716−N729)
according to the manufacturer protocol. The PCR product was
purified by magnetic beads: AMPure XP Beads (A63880).
Each indexed sample was quantified using the Qubit
Fluorometer and diluted to a final concentration 4 nM using
10 mM Tris (pH 8.5). The 91 samples were combined (5 μL/
sample), and the pooled library was quantified using a
NEBNext NGS Library Quant Kit for Illumina (New England
Bio, Cat. No.: E7630S) and sequenced on an Illumina MiSeq
(run id. 180315 M01105 0019 000000000-BKNP7) in the
Interdisciplinary Center for Biotechnology Research, Univer-
sity of Florida according to established protocols.
Analysis of 16s Sequencing Data. 16s rRNA sequences
were first subjected to length filtering and quality filtering using
the Trimmomatic software package.25 Following the quality
filtering, closed OTU picking was performed using the Uclust
algorithm with a 97% sequence similarity threshold.26
Obtained representative sequences were assigned taxonomy
by a Uclust search with a consensus (threshold 0.51, n-hits 3).
Both OTU picking and taxonomy assignments were executed
using the Quantitative Insights into Molecular Ecology
(QIIME)27 framework and used Silva (v123)28 as the 16s
rRNA reference database. As the final step, abundances of
Kyoto Encyclopedia of Genes and Genomes (KEGG)29
orthologs for each sample were predicted using the PICRUSt
model (Phylogenetic Investigation of Communities by
Reconstruction of Unobserved States)30 tool retrained for
the Silva database. Resulting abundance profiles were
summarized according to the KEGG BRITE Metabolism
hierarchy.
Bacterial Metabolome Predictions. The outcome of the
bacterial functional profile (PICRUSt) was used to predict the
shift in bacterial metabolome. The pipeline was thus expanded
by a normalization step based on the algorithm MUSICC31 to
rescale the KO abundances to average gene copy number, with
the final aim to correct the predicted KO counts derived from
the original OTU table. Further, we adapted and reimple-
mented the PRMT (Predicted Relative Metabolomic Turn-
over)32 and the MIMOSA33 approaches to produce microbial
community-wide metabolic potential scores (CMP or PRMT
scores) for each metabolite annotated in the knowledge
database KEGG. The output of the applied workflow is
estimated community-wide metabolic potential scores for each
metabolite per metagenomics sample.
Statistical Analysis of 16s Data. All metagenomic and
metabolomic data (QIIME taxonomy assignment, PICRUSt
metabolic pathways and MIMOSA estimated metabolome)
were analyzed for each gender separately. Only taxa with at
least 1% relative abundance in at least one sample were kept
for the analysis. The PICRUSt KO terms had to pass the 0.1%
relative abundance threshold. The metabolites were considered
for analysis if at least one of the group medians (control or
DEHP) exceeded the value of 0.1.
Both QIIME taxonomy estimates and PICRUST metabolic
pathway estimates data were transformed using centered log-
ratio transformation,34 and a two-way unpaired t test was used
for comparison of the differences between the groups, for each
taxa or KO term separately.
The estimated metabolome was tested by a nonparametric
Mann−Whitney U test. All resulting p values were adjusted for
multiple hypothesis testing using the Benjamini−Hochberg
procedure with a significance threshold of 0.1. The statistical
analyses were performed in R version 3.4.4.35
Analysis of the Glucose and Glycogen in Liver.
Hepatic glycogen levels were measured in duplicate using the
Colorimetric Assay kit (BioVision, no. K646−100) according
the manufacturer’s protocol. A glucose background level was
determined by repeating the protocol without the addition of
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the hydrolysis enzyme mix to obtain glucose levels as per the
protocol. The glucose background was subtracted from the
glycogen readings as per the manufacturer’s suggestion to
obtain an accurate estimate of total glycogen.
Histological Analysis. Three males and four females from
the control group and five males and five females from the
DEHP exposed groups at 2 months were collected for
histopathology. The GI and liver tissues used for histopathol-
ogy were preserved in Davidson’s fixative, embedded in
paraffin, sectioned at 4 μM, and stained with hematoxylin
and eosin. Tissue pathology was assessed by two Veterinary
Board-Certified Pathologists (Drs. Ginn and Craft). Scoring of
tissue was based upon the severity of changes compared to
control sections. Gastrointestinal tissue was evaluated for
evidence of disruption of villus morphology, necrosis of the
epithelial border, and inflammation. For inflammation, the
number of eosinophils at the base of the epithelial cells in the
connective tissue stroma was counted in three fields per
specimen at 60× magnification, and the presence of migrating
lymphocytes was compared between control and experimental
groups. Liver tissue was evaluated for disruption of liver
architecture, presence and degree of hepatocellular lipid
accumulation, inflammation, bile duct hyperplasia, fibrosis,
hepatocyte hypertrophy, and areas of necrosis. The histological
scoring system was adapted from Zodrow et al.36
3. RESULTS AND DISCUSSION
Epidemiological studies link DEHP with numerous adverse
health outcomes.9 However, there are no data investigating the
direct role of the microbiome in DEHP-induced toxicity. It is
noteworthy that DEHP has been reported to affect the
adaptive immune system as a promoter of Th1/Th2 immune
responses.37,38 Earlier studies have also reported that DEHP
may contribute to allergic reactions and act as an adjuvant in
promoting Th2 allergic responses.39 To better understand the
effects of DEHP on these biological processes and the
intestinal immune system, and to reveal interactions between
the host gastrointestinal tissue and the microbiome during
exposure, we leveraged computational approaches and
predictive functional models using multiomics data collected
in male and female zebrafish exposed to dietary DEHP (Figure
1).
To describe the adverse outcome of dietary exposure to
DEHP, we exposed zebrafish to 3 mg of DEHP/kg of feed.
The DEHP content in the feed was confirmed with LC MS/
MS (2.89 ± 0.06 mg/kg). However, while DEHP is associated
with increased adipogenesis,13 two month exposure did not
alter body weight (Figure S2) nor did it induce pathology in
the gastrointestinal system or liver (Figures S3 and S4, Table
S1). This has also been reported in a second exposure study
with DEHP in zebrafish, in that 3 ppm DEHP did not
exacerbate gastrointestinal morphology nor affect BMI during
a high-feeding regime.23 No change in glucose nor glycogen
Figure 1. Proposed DEHP interaction with the host’s microbiome−gastrointestinal−immune system. DEHP was identified to affect both the gut
microbial community and spectrum of biological processes in the gut tissue. DEHP significantly upregulated gene networks associated with helper
T cells’ (Th1, Th2, Th17) specific pathways that, in addition to direct effect of DEHP, may alter the gut integrity and performance via the
downregulation of tight junction (TJ), gap junctional intercellular communication (GJIC), and membrane transportersorganic-anion-
transporting polypeptides (OATPs). DEHP shifted the microbial community and microbial capacity to generate bioactive metabolites. This finding
suggests that the gut microbiota may contribute to the adverse effects of DEHP on the host by altering metabolites sensed by both intestinal and
immune Th cells. DEHP interacts with the expression of intracellular receptors (AhR, PPARs) that regulate cellular metabolism and immunity and
downregulates the production of several hormones (GLP-1, GH1, NPY).
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stores in the liver supports the observation that DEHP at these
realistic exposures may not affect BMI.
Despite a lack of change in higher level responses, there were
many at the molecular level. Gene set enrichment analysis
(GSEA) identified classes of genes that were dysregulated by
DEHP, several of which are associated with Th cells in both
males and females (Table.1). T-cell populations consist of
helper T cell types Th1 and Th2, and their dysregulation is a
marker of inflammatory disease states (Crohn’s disease is
associated with a Th1 cytokine profile, ulcerative colitis with
dysregulation of Th2).40 Another type of T cell, Th17, has an
important role in intestinal inflammation, particularly in
Crohn’s disease.41 Our computational analysis revealed that
DEHP upregulates the spectrum of the Th cell cytokines
specific for Th1 (Il-12, Il-10, Il-22, INFγ), Th2 (Il-13, Il-31),
and Th17 (Il-22; Table S2). Similarly, the intestinal response
in the male group suggested there was activation and
differentiation of Th cells (T cell activation, Th17 cell
differentiation), similar to activation observed in Crohn’s
disease (Table S3). The activation of intestinal populations of
Th cells is supported by differential gene expression analysis
(DGEA) that revealed that the highly affected gene is nf il3
(Nuclear Factor, Interleukin 3), which was upregulated by
DEHP in both males (fold change 15.3) and females (fold
change 10.1; Table S4). NFIL3 regulates Il-3 transcription, a
cytokine that is restricted to activated T cells, natural killer
(NK) cells, and mast cell lines. The upregulation of nf il3 by
DEHP was verified by qPCR which showed the increased level
of nf il3 transcript (Figure S1). DEHP induced T cell (Th1,
Th2, and Th17) activation and differentiation was also
observed in our previous study that evaluated the effect of
DEHP on metabolism and contribution to obesity.23
Th17 plays a key role in the neutralization of pathogens,
partly by the maintenance of the integrity of the intestinal
epithelia via Il-17 and Il-22 production. The observed cytokine
profile, specifically Il-22, suggests that there may be
maintenance of epithelial barriers and promotion of the repair
of damaged epithelia.42 Additionally, mucosal epithelia express
receptors for Th17 cytokines, promoting epithelial barrier
function by tight junction formation and antimicrobial peptide
and mucus production.42 Involvement of the pro-inflammatory
INFγ and Il-31 cytokines is a signature of activated Th cells
regulating intestinal barrier function, specifically tight junc-
tions.43 Epithelial and endothelial barrier function is mostly
maintained by intercellular tight junctions (TJs), that is,
multiprotein complexes that seal the space between adjacent
cells. Studies have highlighted the regulation of the tight
junction barrier by cytokines.44 Upregulated IFN-γ and Il-22,
in addition to other cytokines, e.g., tumor necrosis factor-α
(TNFα), are known for their role in the regulation of tight
junction integrity.43,45,46 Cytokine mediated perturbation of
the function of TJ may result in enhanced paracellular
permeability and increased exposure of tissues to luminal
antigens in organ systems. GSEA revealed that DEHP down-
regulates gene networks associated with the organization and
function of cell−cell junctions primarily involved in adhesion,
specifically tight junctions (TJs) and adherent junctions (AJ),
and gut homeostasis represented by gap junctions (GJs; Tables
S2 and S3). GJ creates the pores coupling adjacent cells to
mediate intercellular activities of GJ called gap junction
intercellular communication (GJIC). Interestingly, the ex-
pression of GCs in females (i.e., GC assembly and regulation)
is downregulated (Table S4). This finding is supported by
significant downregulation of connexin 32.3 (cx32.3), the
transcript of the key GC structure peptide (Table S5).
Inhibition of GJIC may impact the exchange of small
molecules between adjacent cells that is critical for maintaining
tissue homeostasis and integrity. We assume that the
perturbation of GJIC and TJs is caused by a stimulation of
the immune system.44,47 However, the effect of phthalates on
cell−cell communication and TJ and related mode of action is
largely unexplored. There are a few studies demonstrating that
similar types of phthalate, for example, di-n-butyl phthalate,
induce structural and function changes of TJs and GJs in the
testes, both in vivo and in vitro.48,49 However, the mode of
action underlying the disruption is not yet firmly established.
Aberrant immune signals derived from DEHP exposure, in
addition to the associated changes in intestinal barrier function
Table 1. Transcriptomic Analysis of the Intestine of
Zebrafish Males and Females Exposed to DEHPa









males T cell activation 1.23 1.09 0.00
males T-cell receptor signaling 1.31 1.09 0.01
males Th1 cell activation in Crohn’s
disease
1.64 1.27 0.02
males Th17 cell activation in
Crohn’s disease
1.75 1.25 0.01
males Th17 cell differentiation 1.37 1.20 0.04








males central T-cell tolerance 1.39 1.14 0.04
males peripheral T-cell tolerance
overview
1.36 1.19 0.05
males T-cell positive selection and
neglect−induced death
1.65 1.23 0.01
females T-cell receptor → AP-1
signaling
1.52 1.18 0.03





females IL10R → STAT signaling 1.71 1.21 0.01
females IL12R → STAT signaling 1.82 1.21 0.01
females IL13R → STAT signaling 1.82 1.22 0.01
females IL22R → STAT3 signaling 1.65 1.84 0.02
females IL31R → STAT signaling 1.63 1.14 0.03
subnetwork analysis (cell processes)
group pathway/process name median change p value
males T-helper 1 cell activation 1.27 0.03
males T-helper 17 cell differentiation 1.18 0.04
males T-cell tolerance 1.13 0.05
males resting T-cell proliferation 1.27 0.04
males adaptive immune response 1.05 0.03
females T-helper 2 cell differentiation 1.09 0.04
aThe table represents a summary of the T cell specific pathways and
processes identified by gene set enrichment analysis (GSEA) and cell
processes identified by a sub-network analysis. The complete list of
identified effected processes and pathways is in the Supporting
Information (Table S2 females and Table S3 males).
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and integrity, may contribute to dysfunction as revealed via the
subnetwork analysis. The intestinal transcriptomic profile
suggests several common effects for male and female groups
on tissue maintenance, gut development, GI digestion and
secretion, and duodenum motility, among others. There also
appears to be sex specific effects for males in terms of intestinal
transportation and absorption capacity (e.g., effect on lipid
transport and absorption and fatty acid import) and for females
(e.g., intestinal secretion, wall integrity and GI transit; Tables
S2, S3). Moreover, we identify the impact on overall
performance of the gut, as several membrane transport
proteins, organic-anion-transporting polypeptides (OATPs),
encoded by slc genes were negatively affected in the males
(Table S3). OATPs are evolutionary ancient proteins able to
transport ions, hormones, nutrients, and xenobiotics and are a
key player for oral drug absorption.50 Alterations in the
expression and function of OATP drug transporters have been
reported to occur in several disease states including cancer and
inflammatory diseases.51 Several human studies with hepato-
cytes demonstrate a role for the immune system in the
regulation of OATP. Pro-inflammatory TNF-α, IL-6, oncosta-
tin, IL-1β, and IFN-γ downregulate or repress a wide spectrum
of OATPs partially through transcription factors HNF1α
(hepatocyte nuclear factor-1α) and HNF4α (hepatocyte
nuclear factor-4α).51
In addition to GSEA, SNEA confirmed the effect on immune
cells emphasizing the involvement of T cells; as many of the
identified targets are T cell cytokines or T cell receptors of
chemokines or are those that belong to transduction pathways
that lead to cytokine production. We also identified down-
regulation of several hormone networks and/or their receptor
signaling pathways such as growth hormone 1 (GH1),
glucagon-like peptide-1 (GLP-1), and neuropeptide Y (NPY;
Tables S2, S3) at the transcript level. NPY is one of the
hormones that can modify immune activity. NPY is an agonist
of Y class receptor that is expressed in specific immune cells
such as macrophages, dendritic cells, and T and B cells.52 In
addition, immune cells including B and T lymphocytes release
NPY as an autocrine and paracrine immune mediator.53 NPY
negatively regulates T cell function, activates Th cell
differentiation, and can modulate immune cell trafficking,
production of reactive oxygen species, cytokine secretion, and
phagocytosis.52,54 There is evidence that the NPY system has
an impact on the composition and function of the gut
microbiota.52 NPY has been found to exhibit a direct
antimicrobial effect against various gut bacteria including
Escherichia, Enterococcus, and Lactobacillus.55 On the contrary,
the microbiome influences diverse aspects of intestinal
physiology and disease, in part by controlling tissue-specific
transcription of host genes. One of the identified DEHP
affected transcription factors in the intestine were HNF4α and
HNF1α, each of which play an important role in human
metabolic and inflammatory bowel diseases.56 Recently,
genetic analysis revealed that zebrafish hnf4a activates nearly
half of the genes that are suppressed by microbiota, suggesting
microbiota negatively regulate HNF4α.56
Activation of an intestinal immune system and the activation
of microbiome responsive elements appears to underlie DEHP
exposure. We thus conducted a metagenomic analysis of the
intestinal microbiota, as DEHP was hypothesized to shift the
microbiome composition and decrease diversity. Specifically,
we observed an increase in phyla Fusobacteria, Bacteroidetes,
and Verrucomicrobia in both males and females (Figures S5 and
S6). On a class level, DEHP exposure increased Bacteroidia and
Gammaproteobacteria and decreased Verrucomicrobiae in both
sexes. Further, in males we found an increase in classes
Fusobacteriia and Betaproteobacteria and a decrease in
Saccharibacteria (Figure 2). The shift of the microbiome
does not necessarily reflect the change in microbial functional
capabilities.30 A computational approach that predicts the
functional composition of the metagenome revealed metabolic
and biosynthetic pathways involved in the production of
bioactive metabolites. In contrast to males, the predicted
microbial functional shift in females involved metabolism-
related categories (e.g., decreased oxidative phosphorylation
and benzoate degradation; Figure S7). In males, there was a
predicted increased capacity for glycerophospholipid metabo-
lism, proposed to be associated with choline and lower
tryptophan metabolism (Figure S8). We next used predicted
community enzyme function profiling to model microbial
Figure 2. Comparison of the effect of phthalate DEHP on microbial classes between control and exposed group in male and female groups. Radar
charts represent the shift in the specific microbial class expressed as the difference between median abundance of control and exposed groups. The
bars under each microbial class represent the precentral abundance (%) of each class within the control or exposed group. Statistically significant
effects on the abundance of the microbial class is marked in red.
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metabolites using Predicted Relative Metabolic Turnover
(PRMT;57,58 Figure 3). Our model showed several microbial
metabolites that may, in addition to a direct effect of DEHP,
contribute to immune and intercellular communication. Our
predictions revealed decreased L-glutamine in males and D-
fructose 6-phosphate in females; these metabolites are
beneficial to diverse immune functions. Moreover, these
metabolites require precise control of cellular metabolic
pathways and impact immune cells and enterocytes. For
example, lower L-glutamine may impact L-citrulline levels, a
biomarker of short bowel syndrome (SBS).59 Citrulline is also
lower in adenovirus enteritis and all infectious intestinal
diseases with high cytopathic effects.60
Further, we found a predicted increase in the turnover of
metabolites with immunomodulatory potency, specifically
choline in the males and thioguanine (TG) in females (Figure
3). Choline is actively metabolized to methylamines (e.g.,
trimethylamine-N-oxide; TMAO) which have been shown to
be involved in many diseases such as obesity, diabetes, and
cancers including autoimmune deseases.61 TMAO upregulates
the inflammatory pathways leading to increased production of
pro-inflammatory cytokines.62 TG is a member of thiopurines,
an active ingredient of IBD drugs, that induce immunosup-
pression, one of which reduces proliferation of cancerous
cells.63 In addition to positive effects on IBD, these chemicals
induce oxidative stress and apoptosis specifically in Th
cells.63−65 On the basis of the response in the zebrafish
intestine, we posit that tryptophan metabolites may also play a
role in immune related effects. However, GSEA identified the
increased tryptophan metabolism in the intestine; we found a
predicted decrease of tryptophan metabolic turnover in
microbial communities. Tryptophan metabolites are converted
from tryptophan in the lumen of the gut and regulate aryl-
hydrocarbon receptor (AhR) signaling in a broad spectrum of
cells. The AhR is a ligand-inducible transcription factor/
receptor that is highly expressed by epithelial cells and immune
cells, both the Il-17/Il-22 producing and nonproducing Th
cells.66,67 Tryptophan levels thus regulate T cells (i.e.,
regulators of differentiation of T lymphocytes into pro-
inflammatory Th 17 cells) and promote AhR-dependent
production of Il-22, a key cytokine involved in maintenance
of epithelial barriers and repair processes.68 Further, there are
additional metabolites that link the effect on Th cells and the
dysregulated microbiome, thioredoxin, that is part of
thioredoxin system (Trx) that is suggested to be the critical
pathway controlling T-cell activation and expansion.69
Upregulated Trx has been reported in several types of cancers
and deregulated T cells (e.g., aggressive T-cell lymphoblastic
leukemia).69
The observed effects, i.e., dysregulated genes and biological
processes, are proposed to be early events that may lead to
DEHP-induced abnormalities. We evaluated several apical end
points to connect the early events to specific adverse outcomes.
In spite of a dramatic shift in several biomarkers of the
microbiome−gut axis, there were no histological differences
between control and DEHP exposed animals in the liver or gut
tissue (Figures S3 and S4, Table S1). To link the observed
effect with DEHP associated lipid disbalance and increase in
energy storage, we measured weight gain (Figure S2) and
glucose and glycogen (Figure S9) levels in livers. We did not
detect any significant changes among control and DEHP-
exposed animals, and there was high individual variability in
glucose and glycogen levels.
In conclusion, we leverage a multiomics approach (e.g.,
transcriptomic analysis with metagenomics) to systematically
obtain a deeper understanding into the processes that may lead
to adverse outcomes reported in other studies with plasticizers.
We report that DEHP modulates several biological processes
that affect complex intestinal performance. We assume that
these effects are due in part to a direct effect of DEHP on the
intestine but are also mediated via dysregulated adaptive
immunity, specifically Th cells. The latest advances in
bioinformatics allowed us to predict the effects of DEHP on
microbiome−gut mutual signaling and to confirm the role of
Figure 3. Significant changes in predicted relative metabolic turnover (PRMT) of microbial metabolites in control and DEHP exposed (phthalates)
male and female groups.
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microbial bioactive metabolites on the dysregulation of the
host immune system. The identified immunity−microbiome
network altered by DEHP is expected to lead to a deeper
understanding of plasticizers and adverse health outcomes
identified in human cohort studies.
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